XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Disponible des:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

Designació comuna internacional (DCI):

levocetirizine dihydrochloride

formulario farmacéutico:

Oral Liquid

Composición:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Vía de administración:

Oral

Unidades en paquete:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

tipo de receta:

(S2) Pharmacy Medicine

indicaciones terapéuticas:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Resumen del producto:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Registered

Data d'autorització:

2010-01-19